Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2018 Feb 1;178(2):292-294.
doi: 10.1001/jamainternmed.2017.7856.

Gabapentinoid Use in the United States 2002 Through 2015

Michael E Johansen  1   2
Affiliations
Multicenter Study

Gabapentinoid Use in the United States 2002 Through 2015

Michael E Johansen. JAMA Intern Med. .

Abstract

This cohort study uses 2002-2015 Medical Expenditure Panel Survey data to characterize the use of gabapentinoids among the US adult population.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure 1.
Figure 1.. Gabapentinoid Use in the United States, 2002 Through 2015
The figure identifies the proportion of adults (>17 years) who reported a filled prescription for gabapentin, pregabalin, or a gabapentinoid during a calendar year between 2002 and 2015.
Figure 2.
Figure 2.. Gabapentinoid Use by Subgroups, 2002 Through 2015
The figure identifies the proportion of gabapentinoid users among adults stratified by age (<65 vs ≥65 years), presence of diabetes, Elixhauser comorbidity index, and concomitant use of opioids (0-2 and ≥3 prescriptions) and benzodiazepines (any benzodiazepine prescription).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Kesselheim AS, Darby D, Studdert DM, Glynn R, Levin R, Avorn J. False Claims Act prosecution did not deter off-label drug use in the case of neurontin. Health Aff (Millwood). 2011;30(12):2318-2327. - PubMed
    1. Shanthanna H, Gilron I, Rajarathinam M, et al. . Benefits and safety of gabapentinoids in chronic low back pain: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2017;14(8):e1002369. - PMC - PubMed
    1. Schifano F. Misuse and abuse of pregabalin and gabapentin: cause for concern? CNS Drugs. 2014;28(6):491-496. - PubMed
    1. Gomes T, Juurlink DN, Antoniou T, Mamdani MM, Paterson JM, van den Brink W. Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case-control study. PLoS Med. 2017;14(10):e1002396. - PMC - PubMed
    1. Mathieson S, Maher CG, McLachlan AJ, et al. . Trial of pregabalin for acute and chronic sciatica. N Engl J Med. 2017;376(12):1111-1120. - PubMed

Publication types